Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway

Author：                

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.41, Iss.3, 2012-01, pp. : 949-958

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathway

By            

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 205-210

Spandidos Publications

Access to resources Recommend Favorite

Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3027-3034

Spandidos Publications

Access to resources Recommend Favorite

Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer

By            

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 792-798

Spandidos Publications

Access to resources Recommend Favorite

Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK

By              

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 975-982

Spandidos Publications

Access to resources Recommend Favorite

Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3249-3256

Spandidos Publications

Access to resources Recommend Favorite